They are not intended to represent clinical evidence in humans, and Dihexa has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Commonly reported side effects like headache, weakness, inflamed tongue, burning sensation in limbs, nausea, and stuffy nose should be monitored and communicated to a healthcare provider if they worsen
possibly related to NO-mediated vasodilation
The safety profile is comparable across injection, oral, and sublingual forms
This stems from the fact that the formation of new capillaries increases blood perfusion to the wound, provides nutrients, and removes metabolites
GHK-Cu and matrix metalloproteinase-2 expression in fibroblast cultures